Article: Clinical Sciences receives FDA approval to market new diagnostic test for viral infection. (Clin-Elisa CMV IgM for detection of cytomegalovirus)

CLINICAL SCIENCES RECEIVES FDA APPROVAL TO MARKET

NEW DIAGNOSTIC TEST FOR VIRAL INFECTION

WHIPPANY, N.J., April 12 /PRNewswire/ -- Clinical Sciences Inc. (NASDAQ: CLSC), an affiliate of the FIAT Group, today announced it has received approval from the Food and Drug Administration to begin marketing a diagnostic test for the detection of cytomegalovirus (CMV). The test, Clin-Elisa CMV IgM, is a microplate Elisa test system, which detects the presence of IgM antibodies specific to CMV in human serum.

CMV is one of the more common causes of congenital viral infections and can result in serious illness and birth defects in ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!